In December 2005 the four major Swiss zoos carried out the vaccination of selected zoo birds with the adjuvant inactivated vaccine H5N2 Nobilis influenza. Within the non-Galliformes, significant differences in geometric mean titres were found among different species representatives. In general, the flamingos (Phoenicopteriformes) showed a strong response to vaccination reaching a geometric mean titre of 659 at week 10, while the Sphenisciformes did not show high antibody titres even after booster vaccination, reaching a maximum geometric mean titre of only 65. Based on the antibody titre profiles of all investigated species, researchers recommend at least annual revaccination in the species that were investigated.
Study Results
In December 2005 the four major Swiss zoos carried out the vaccination of selected zoo birds with the adjuvant inactivated vaccine H5N2 Nobilis influenza. Within the non-Galliformes, significant differences in geometric mean titres were found among different species representatives. In general, the flamingos (Phoenicopteriformes) showed a strong response to vaccination reaching a geometric mean titre of 659 at week 10, while the Sphenisciformes did not show high antibody titres even after booster vaccination, reaching a maximum geometric mean titre of only 65. Based on the antibody titre profiles of all investigated species, researchers recommend at least annual revaccination in the species that were investigated.
Significance of Study Results
This study suggests that it can be shown that vaccination in a multispecies collection is well tolerated and will result in significant humoral immune response. However, no conclusions regarding protectivity of the titres of non-Galliformes can be made at this point. Vaccination may be a useful strategy to save exotic and valuable birds from confinement and pre-emptive culling in view of a potential outbreak of avian influenza (AI).
Additional Information
Highly pathogenic and notifiable low pathogenic avian influenza viruses pose a special peril to zoos, considering that the birds they keep often are of great value from the point of view of conservation. The disease poses a twofold threat, by either the epidemic itself or by the control measures adopted in case of a notifiable avian influenza virus is identified in the population, which often include culling or stamping out of birds within the affected areas. Because treatment of avian influenza in birds is not considered an option, prevention of the disease by vaccination has been recommended.
Commercial vaccines are available for poultry and it has been shown that such vaccines also protect ducks. It was demonstrated that vaccinated birds do not develop clinical signs when infected with the challenge viruses and show vaccinated ducks had reduced shedding of the challenge virus. Vaccination has also been discussed as an option to protect rare species in zoological gardens. Vaccination studies of multispecies bird collections in zoos have been carried out with H7N2 and H5N2 vaccines in Dutch zoos, with H5N2 vaccine at Singapore zoos and with H5N9 vaccine in Danish zoos. From these reports, it could be concluded that vaccination is safe and that the vaccine elicits a humoral immune response. However, there are also reports in these studies describing differences in antibody mediated immune responses among avian species. Furthermore antibody titre profiles over an extended period of several months were not investigated in non-domestic birds. In Galliformes, annual boostering is recommended but the interval for other species is not known.
Approximately six months after the initial vaccination, titres were decreased leading to the conclusion that annual revaccination appears warranted in zoo birds as in chickens in high-risk areas. In certain species such as penguins, shorter intervals may even be necessary. However, further work on the susceptibility to AI of species other than Galliformes and Anseriformes is needed to make conclusive recommendations. Summarized from Avian Diseases, Vol. 52, No. 2, 2008, Pages 222-228 
